{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,24]],"date-time":"2025-10-24T08:10:18Z","timestamp":1761293418431,"version":"3.40.5"},"reference-count":38,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2016,7,1]],"date-time":"2016-07-01T00:00:00Z","timestamp":1467331200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,5,26]],"date-time":"2016-05-26T00:00:00Z","timestamp":1464220800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000265","name":"Medical Research Council","doi-asserted-by":"publisher","award":["MR\/J008176\/1","MR\/L00903X\/1"],"award-info":[{"award-number":["MR\/J008176\/1","MR\/L00903X\/1"]}],"id":[{"id":"10.13039\/501100000265","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004963","name":"European Union Seventh Framework Programme","doi-asserted-by":"publisher","award":["614562"],"award-info":[{"award-number":["614562"]}],"id":[{"id":"10.13039\/501100004963","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Lister Institute for Preventive Medicine and a Royal Society Wolfson Research Merit Award"},{"DOI":"10.13039\/100004440","name":"Wellcome Trust","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004440","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003971","name":"Islamic Development Bank","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003971","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.jp","ijaaonline.com","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Antimicrobial Agents"],"published-print":{"date-parts":[[2016,7]]},"DOI":"10.1016\/j.ijantimicag.2016.04.018","type":"journal-article","created":{"date-parts":[[2016,5,26]],"date-time":"2016-05-26T17:45:38Z","timestamp":1464284738000},"page":"69-77","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":21,"title":["Novel cell-based in vitro screen to identify small-molecule inhibitors against intracellular replication of Cryptococcus neoformans in macrophages"],"prefix":"10.1016","volume":"48","author":[{"given":"Sweta","family":"Samantaray","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joao N.","family":"Correia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mariam","family":"Garelnabi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kerstin","family":"Voelz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5364-1838","authenticated-orcid":false,"given":"Robin C.","family":"May","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4908-8168","authenticated-orcid":false,"given":"Rebecca A.","family":"Hall","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijantimicag.2016.04.018_bib0010","doi-asserted-by":"crossref","first-page":"4345","DOI":"10.1128\/IAI.00542-09","article-title":"Spores as infectious propagules of Cryptococcus neoformans","volume":"77","author":"Velagapudi","year":"2009","journal-title":"Infect Immun"},{"key":"10.1016\/j.ijantimicag.2016.04.018_bib0015","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1097\/QAD.0b013e328322ffac","article-title":"Estimation of the current global burden of cryptococcal meningitis among persons living with HIV\/AIDS","volume":"23","author":"Park","year":"2009","journal-title":"AIDS"},{"key":"10.1016\/j.ijantimicag.2016.04.018_bib0020","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1001316","article-title":"Cryptococcal meningitis treatment strategies in resource-limited settings: a cost-effectiveness analysis","volume":"9","author":"Rajasingham","year":"2012","journal-title":"PLoS Med"},{"key":"10.1016\/j.ijantimicag.2016.04.018_bib0025","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/j.bjid.2012.10.020","article-title":"Strategies to reduce mortality and morbidity due to AIDS-related cryptococcal meningitis in Latin America","volume":"17","author":"Vidal","year":"2013","journal-title":"Braz J Infect Dis"},{"key":"10.1016\/j.ijantimicag.2016.04.018_bib0030","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1258\/ijsa.2010.010182","article-title":"An update on Cryptococcus among HIV-infected patients","volume":"21","author":"Warkentien","year":"2010","journal-title":"Int J STD AIDS"},{"key":"10.1016\/j.ijantimicag.2016.04.018_bib0035","doi-asserted-by":"crossref","first-page":"4225","DOI":"10.1128\/IAI.68.7.4225-4237.2000","article-title":"Cryptococcus neoformans is a facultative intracellular pathogen in murine pulmonary infection","volume":"68","author":"Feldmesser","year":"2000","journal-title":"Infect Immun"},{"key":"10.1016\/j.ijantimicag.2016.04.018_bib0040","doi-asserted-by":"crossref","first-page":"3165","DOI":"10.1073\/pnas.052702799","article-title":"Replication of Cryptococcus neoformans in macrophages is accompanied by phagosomal permeabilization and accumulation of vesicles containing polysaccharide in the cytoplasm","volume":"99","author":"Tucker","year":"2002","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.ijantimicag.2016.04.018_bib0045","doi-asserted-by":"crossref","first-page":"3450","DOI":"10.1128\/IAI.00297-09","article-title":"Cytokine signaling regulates the outcome of intracellular macrophage parasitism by Cryptococcus neoformans","volume":"77","author":"Voelz","year":"2009","journal-title":"Infect Immun"},{"key":"10.1016\/j.ijantimicag.2016.04.018_bib0050","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1111\/cmi.12394","article-title":"The fungal pathogen Cryptococcus neoformans manipulates macrophage phagosome maturation","volume":"17","author":"Smith","year":"2015","journal-title":"Cell Microbiol"},{"key":"10.1016\/j.ijantimicag.2016.04.018_bib0055","doi-asserted-by":"crossref","first-page":"2219","DOI":"10.4049\/jimmunol.1402376","article-title":"Cryptococcus neoformans-induced macrophage lysosome damage crucially contributes to fungal virulence","volume":"194","author":"Davis","year":"2015","journal-title":"J Immunol"},{"key":"10.1016\/j.ijantimicag.2016.04.018_bib0060","doi-asserted-by":"crossref","first-page":"2156","DOI":"10.1016\/j.cub.2006.09.032","article-title":"Expulsion of live pathogenic yeast by macrophages","volume":"16","author":"Ma","year":"2006","journal-title":"Curr Biol"},{"key":"10.1016\/j.ijantimicag.2016.04.018_bib0065","doi-asserted-by":"crossref","first-page":"2161","DOI":"10.1016\/j.cub.2006.09.061","article-title":"Phagosome extrusion and host-cell survival after Cryptococcus neoformans phagocytosis by macrophages","volume":"16","author":"Alvarez","year":"2006","journal-title":"Curr Biol"},{"year":"2011","series-title":"Rapid advice: diagnosis, prevention and management of cryptococcal disease in HIV-infected adults, adolescents and children","author":"World Health Organization","key":"10.1016\/j.ijantimicag.2016.04.018_bib0070"},{"key":"10.1016\/j.ijantimicag.2016.04.018_bib0075","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1086\/649858","article-title":"Clinical practice guidelines for the management of cryptococcal disease: 2010 update by the Infectious Diseases Society of America","volume":"50","author":"Perfect","year":"2010","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijantimicag.2016.04.018_bib0080","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1086\/592117","article-title":"Amphotericin B: the higher the dose, the higher the toxicity","volume":"47","author":"Pasqualotto","year":"2008","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijantimicag.2016.04.018_bib0085","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1128\/EC.00314-12","article-title":"A repurposing approach identifies off-patent drugs with fungicidal cryptococcal activity, a common structural chemotype, and pharmacological properties relevant to the treatment of cryptococcosis","volume":"12","author":"Butts","year":"2013","journal-title":"Eukaryot Cell"},{"key":"10.1016\/j.ijantimicag.2016.04.018_bib0090","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1093\/jac\/46.2.171","article-title":"Flucytosine: a review of its pharmacology, clinical indications, pharmacokinetics, toxicity and drug interactions","volume":"46","author":"Vermes","year":"2000","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijantimicag.2016.04.018_bib0095","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0015968","article-title":"Automated analysis of cryptococcal macrophage parasitism using GFP-tagged cryptococci","volume":"5","author":"Voelz","year":"2010","journal-title":"PLoS ONE"},{"key":"10.1016\/j.ijantimicag.2016.04.018_bib0100","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1177\/108705719900400206","article-title":"A simple statistical parameter for use in evaluation and validation of high throughput screening assays","volume":"4","author":"Zhang","year":"1999","journal-title":"J Biomol Screen"},{"key":"10.1016\/j.ijantimicag.2016.04.018_bib0105","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/j.apsb.2014.06.005","article-title":"A cell-based high-throughput approach to identify inhibitors of influenza A virus","volume":"4","author":"Gao","year":"2014","journal-title":"Acta Pharm Sin B"},{"key":"10.1016\/j.ijantimicag.2016.04.018_bib0110","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1038\/nrm2515","article-title":"Phagosome maturation: going through the acid test","volume":"9","author":"Kinchen","year":"2008","journal-title":"Nat Rev Mol Cell Biol"},{"key":"10.1016\/j.ijantimicag.2016.04.018_bib0115","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1034\/j.1600-0854.2002.030302.x","article-title":"A microbial strategy to multiply in macrophages: the pregnant pause","volume":"3","author":"Swanson","year":"2002","journal-title":"Traffic"},{"key":"10.1016\/j.ijantimicag.2016.04.018_bib0120","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1002551","article-title":"Sleeping with the enemy: how intracellular pathogens cope with a macrophage lifestyle","volume":"8","author":"Thi","year":"2012","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.ijantimicag.2016.04.018_bib0125","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1191\/096032701680350523","article-title":"Effects of the antianginal drug fendiline on Ca2+ movement in hepatoma cells","volume":"20","author":"Cheng","year":"2001","journal-title":"Hum Exp Toxicol"},{"key":"10.1016\/j.ijantimicag.2016.04.018_bib0130","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1177\/0960327108097436","article-title":"Fendiline-evoked [Ca2+]i rises and non-Ca2+-triggered cell death in human oral cancer cells","volume":"28","author":"Huang","year":"2009","journal-title":"Hum Exp Toxicol"},{"key":"10.1016\/j.ijantimicag.2016.04.018_bib0135","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1016\/S0024-3205(02)01797-6","article-title":"The anti-anginal drug fendiline elevates cytosolic Ca2+ in rabbit corneal epithelial cells","volume":"71","author":"Lin","year":"2002","journal-title":"Life Sci"},{"key":"10.1016\/j.ijantimicag.2016.04.018_bib0140","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1093\/jac\/dkq046","article-title":"Polymyxin B, in combination with fluconazole, exerts a potent fungicidal effect","volume":"65","author":"Zhai","year":"2010","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijantimicag.2016.04.018_bib0145","article-title":"Synergistic antifungal effect of glabridin and fluconazole","volume":"9","author":"Liu","year":"2014","journal-title":"PLoS ONE"},{"key":"10.1016\/j.ijantimicag.2016.04.018_bib0150","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1003946","article-title":"Identification of host-targeted small molecules that restrict intracellular Mycobacterium tuberculosis growth","volume":"10","author":"Stanley","year":"2014","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.ijantimicag.2016.04.018_bib0155","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.exppara.2009.02.012","article-title":"Leishmania (Viannia) panamensis: an in vitro assay using the expression of GFP for screening of antileishmanial drug","volume":"122","author":"Varela","year":"2009","journal-title":"Exp Parasitol"},{"key":"10.1016\/j.ijantimicag.2016.04.018_bib0160","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1128\/MCB.00884-12","article-title":"Fendiline inhibits K-Ras plasma membrane localization and blocks K-Ras signal transmission","volume":"33","author":"van der Hoeven","year":"2013","journal-title":"Mol Cell Biol"},{"key":"10.1016\/j.ijantimicag.2016.04.018_bib0165","doi-asserted-by":"crossref","first-page":"331","DOI":"10.3389\/fphys.2014.00331","article-title":"Inhibition of acid sphingomyelinase by tricyclic antidepressants and analogons","volume":"5","author":"Beckmann","year":"2014","journal-title":"Front Physiol"},{"key":"10.1016\/j.ijantimicag.2016.04.018_bib0170","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1021\/jm070524a","article-title":"Identification of new functional inhibitors of acid sphingomyelinase using a structure\u2212property\u2212activity relation model","volume":"51","author":"Kornhuber","year":"2008","journal-title":"J Med Chem"},{"key":"10.1016\/j.ijantimicag.2016.04.018_bib0175","doi-asserted-by":"crossref","first-page":"9473","DOI":"10.1523\/JNEUROSCI.1867-08.2008","article-title":"Inhibitors of cytochrome c release with therapeutic potential for Huntington's disease","volume":"28","author":"Wang","year":"2008","journal-title":"J Neurosci"},{"key":"10.1016\/j.ijantimicag.2016.04.018_bib0180","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.fgb.2014.12.001","article-title":"Toward improved anti-cryptococcal drugs: novel molecules and repurposed drugs","volume":"78","author":"Krysan","year":"2015","journal-title":"Fungal Genet Biol"},{"key":"10.1016\/j.ijantimicag.2016.04.018_bib0185","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1023\/A:1009935116877","article-title":"Drug levels: therapeutic and toxic serum\/plasma concentrations of common drugs","volume":"15","author":"Regenthal","year":"1999","journal-title":"J Clin Monit Comput"},{"key":"10.1016\/j.ijantimicag.2016.04.018_bib0190","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0005305","article-title":"Voltage gated calcium channels negatively regulate protective immunity to Mycobacterium tuberculosis","volume":"4","author":"Gupta","year":"2009","journal-title":"PLoS ONE"},{"key":"10.1016\/j.ijantimicag.2016.04.018_bib0195","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.cell.2011.02.022","article-title":"Drug tolerance in replicating mycobacteria mediated by a macrophage-induced efflux mechanism","volume":"145","author":"Adams Kristin","year":"2011","journal-title":"Cell"}],"container-title":["International Journal of Antimicrobial Agents"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924857916300966?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924857916300966?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,11]],"date-time":"2018-09-11T14:22:48Z","timestamp":1536675768000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0924857916300966"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,7]]},"references-count":38,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2016,7]]}},"alternative-id":["S0924857916300966"],"URL":"https:\/\/doi.org\/10.1016\/j.ijantimicag.2016.04.018","relation":{},"ISSN":["0924-8579"],"issn-type":[{"type":"print","value":"0924-8579"}],"subject":[],"published":{"date-parts":[[2016,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Novel cell-based in vitro screen to identify small-molecule inhibitors against intracellular replication of Cryptococcus neoformans in macrophages","name":"articletitle","label":"Article Title"},{"value":"International Journal of Antimicrobial Agents","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijantimicag.2016.04.018","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}